Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20766) 20766
Newsletter (5804) 5804
Newspaper Article (2720) 2720
Publication (2023) 2023
Trade Publication Article (720) 720
Magazine Article (518) 518
Book Review (162) 162
Government Document (141) 141
Dissertation (107) 107
Conference Proceeding (95) 95
Book Chapter (91) 91
Book / eBook (67) 67
Web Resource (8) 8
Data Set (7) 7
Paper (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (25782) 25782
cancer (10744) 10744
humans (10569) 10569
male (10389) 10389
research (9590) 9590
index medicus (9291) 9291
oncology (6368) 6368
oncology, experimental (5532) 5532
prostatic neoplasms - pathology (5333) 5333
aged (4377) 4377
middle aged (4231) 4231
urology & nephrology (4185) 4185
care and treatment (4101) 4101
prostate (3909) 3909
urology (3577) 3577
metastasis (3484) 3484
reports (3167) 3167
diagnosis (3073) 3073
health aspects (2808) 2808
analysis (2594) 2594
risk factors (2569) 2569
prostatic neoplasms - genetics (2527) 2527
prostatic neoplasms - metabolism (2458) 2458
genetic aspects (2445) 2445
biopsy (2283) 2283
development and progression (2226) 2226
cell line, tumor (2217) 2217
tumors (2201) 2201
prognosis (2165) 2165
radical prostatectomy (2136) 2136
expression (2127) 2127
men (1980) 1980
animals (1856) 1856
androgens (1851) 1851
prostatic neoplasms - diagnosis (1808) 1808
gene expression (1779) 1779
physical fitness (1748) 1748
apoptosis (1693) 1693
prostate-specific antigen - blood (1665) 1665
surgery (1544) 1544
prostate-specific antigen (1529) 1529
aged, 80 and over (1493) 1493
prostatic neoplasms - surgery (1485) 1485
proteins (1476) 1476
risk (1451) 1451
antigens (1415) 1415
mortality (1410) 1410
prostatectomy (1353) 1353
carcinoma (1331) 1331
article (1319) 1319
medicine (1310) 1310
medical research (1304) 1304
prostatic neoplasms - blood (1303) 1303
magnetic resonance imaging (1302) 1302
patients (1290) 1290
universities and colleges (1289) 1289
mice (1283) 1283
progression (1275) 1275
prostate - pathology (1255) 1255
biomarkers (1250) 1250
radiotherapy (1232) 1232
prostatic neoplasms - drug therapy (1195) 1195
cancer therapies (1191) 1191
urologic and male genital diseases (1189) 1189
cell biology (1178) 1178
studies (1168) 1168
adult (1141) 1141
cells (1074) 1074
cancer patients (1069) 1069
androgen receptor (1065) 1065
neoplasm grading (1054) 1054
gene expression regulation, neoplastic (1053) 1053
survival (1046) 1046
prostatic neoplasms (1015) 1015
retrospective studies (1015) 1015
neoplasm staging (1012) 1012
research article (982) 982
growth (970) 970
genes (966) 966
prostatic neoplasms - therapy (962) 962
biochemistry & molecular biology (931) 931
endocrinology & metabolism (905) 905
disease progression (902) 902
immunohistochemistry (878) 878
therapy (868) 868
metastases (864) 864
antigen (860) 860
usage (859) 859
cell proliferation (850) 850
pathology (837) 837
multidisciplinary sciences (820) 820
treatment outcome (819) 819
signal transduction (775) 775
breast-cancer (768) 768
patient outcomes (764) 764
physiological aspects (763) 763
radiology, nuclear medicine & medical imaging (748) 748
cell cycle (742) 742
radiation therapy (739) 739
prostatic neoplasms - mortality (733) 733
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Online Resources - Online (2) 2
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Scarborough Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29907) 29907
German (236) 236
Spanish (158) 158
French (113) 113
Chinese (73) 73
Russian (43) 43
Portuguese (33) 33
Japanese (23) 23
Turkish (13) 13
Italian (8) 8
Polish (5) 5
Dutch (3) 3
Hebrew (2) 2
Afrikaans (1) 1
Arabic (1) 1
Catalan (1) 1
Czech (1) 1
Danish (1) 1
Korean (1) 1
Lithuanian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
by Shui, Irene M and Lindström, Sara and Kibel, Adam S and Berndt, Sonja I and Campa, Daniele and Gerke, Travis and Penney, Kathryn L and Albanes, Demetrius and Berg, Christine and Bueno-de-Mesquita, H. Bas and Chanock, Stephen and Crawford, E. David and Diver, W. Ryan and Gapstur, Susan M and Gaziano, J. Michael and Giles, Graham G and Henderson, Brian and Hoover, Robert and Johansson, Mattias and Le Marchand, Loic and Ma, Jing and Navarro, Carmen and Overvad, Kim and Schumacher, Fredrick R and Severi, Gianluca and Siddiq, Afshan and Stampfer, Meir and Stevens, Victoria L and Travis, Ruth C and Trichopoulos, Dimitrios and Vineis, Paolo and Mucci, Lorelei A and Yeager, Meredith and Giovannucci, Edward and Kraft, Peter and Medicinska fakulteten and Umeå universitet and Enheten för biobanksforskning
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 6, pp. 1069 - 1075
Abstract Background Screening and diagnosis of prostate cancer (PCa) is hampered by an inability to predict who has the potential to develop fatal disease and... 
Urology | Risk single nucleotide polymorphisms | Genetic epidemiology | Prostate cancer | Prostate cancer mortality | MORTALITY | 8Q24 | SUSCEPTIBILITY | GENETIC-VARIANTS | LOCI | DEATH | DISEASE | MEN | UROLOGY & NEPHROLOGY | GENOME-WIDE ASSOCIATION | United States - epidemiology | European Continental Ancestry Group - genetics | Risk Assessment | Humans | Middle Aged | Proportional Hazards Models | Europe - epidemiology | Genotype | Male | Australia - epidemiology | Case-Control Studies | Prostatic Neoplasms - mortality | Prostatic Neoplasms - genetics | Alleles | Registries | Aged | Biomarkers, Tumor - genetics | Polymorphism, Single Nucleotide | Nuclear radiation | Mortality | Breast cancer | Diagnosis | Health aspects | Medicine, Preventive | Risk factors | Public health | Preventive health services | Cancer | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
by Jeet, Varinder and Tevz, Gregor and Lehman, Melanie and Hollier, Brett and Nelson, Colleen
Endocrine-Related Cancer, ISSN 1351-0088, 10/2014, Volume 21, Issue 5, pp. 723 - 737
Chitinase 3-like 1 (CHI3L1 or YKL40) is a secreted glycoprotein highly expressed in tumours from patients with advanced stage cancers, including prostate... 
Metastasis | Cell invasion | Targeted therapy | Prostate cancer | Cell migration | YKL40 | SECRETED GLYCOPROTEIN | targeted therapy | ANDROGEN RECEPTOR | PROTEIN | BIOMARKER | SERUM YKL-40 LEVELS | BREAST-CANCER | prostate cancer | ONCOLOGY | metastasis | PATHWAY | ENDOCRINOLOGY & METABOLISM | cell migration | cell invasion | EXPRESSION | PROGRESSION | Phenylthiohydantoin - pharmacology | Cell Line | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Neoplasm Invasiveness | Humans | Middle Aged | Androgen Antagonists - pharmacology | Male | Adipokines - metabolism | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Chitinase-3-Like Protein 1 | Lectins - metabolism | Androgens - pharmacology | Aged, 80 and over | Cell Line, Tumor | Dihydrotestosterone - pharmacology | Aged | Metribolone - pharmacology | Cell Movement | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Imaging prostate cancer (PCa) with [99mTc(CO)3]finasteride dithiocarbamate
by Shah, Syed Qaiser and Gul‐e‐Raana and Uddin, Ghias
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 06/2018, Volume 61, Issue 7, pp. 550 - 556
This investigation aimed to modify finasteride ( 1 ) to finasteride dithiocarbamate ( 2 ) for subsequent synthesis of the rhenium analogue ( 3 ) and [ 99m... 
prostate cancer | tricarbonyl technique | animal model | finasteride dithiocarbamate | CHEMISTRY, ANALYTICAL | CHEMISTRY, MEDICINAL | BIOCHEMICAL RESEARCH METHODS | FINASTERIDE | CELL-LINES | MEMBRANE ANTIGEN PSMA | MONOCLONAL-ANTIBODY J591 | TRIAL | THERAPY | RADIOPHARMACEUTICALS | INHIBITORS | CARCINOMA | Prostate cancer | Finasteride
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. “GIVE ME FIVE” ULTRA HYPOFRACTIONATED RADIOTHERAPY (RT) FOR LOCALIZED PROSTATE CANCER (PCA): SAFETY WITHOUT LOSING EFFICACY
by Giulia Marvaso and Giulia Riva and Delia Ciardo and Sara Gandini and Cristiana Fodor and Dario Zerini and Stefania Comi and Federica Cattani and Ottavio De Cobelli and Roberto Orecchia and Barbara A Jereczek-Fossa
Anticancer Research, ISSN 0250-7005, 04/2018, Volume 38, Issue 4, p. 2527
Background/Aim: Ultra-hypofractionated radiotherapy (RT) is given over a shorter time with larger doses per treatment in patients with localized prostate... 
Evaluation | Deprivation | Immunoglobulins | Risk groups | Toxicity | Prostate-specific antigen | Test procedures | Radiation | Risk | Biochemistry | Radiation therapy | Patients | Survival | Quality of life | Rank tests | Heterogeneity | Medical prognosis | Prostate cancer | Prostate | Cancer
Journal Article
Details down arrow
5. Full Text Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS)
by Ferro, Matteo and Ungaro, Paola and Cimmino, Amelia and Lucarelli, Giuseppe and Busetto, Gian Maria and Cantiello, Francesco and Damiano, Rocco and Terracciano, Daniela
International Journal of Molecular Sciences, ISSN 1661-6596, 06/2017, Volume 18, Issue 6, p. 1146
Widespread prostate-specific antigen (PSA) testing notably increased the number of prostate cancer (PCa) diagnoses. However, about 30% of these patients have... 
Prostate cancer | Epigenetic biomarkers | Active surveillance | PTEN LOSS | METHYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOPSY | RADICAL PROSTATECTOMY | epigenetic biomarkers | CHEMISTRY, MULTIDISCIPLINARY | prostate cancer | INCREASED RISK | MOLECULAR-DETECTION | ANDROGEN-RECEPTOR | HEALTH INDEX | EXPRESSION | active surveillance | PROGRESSION | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Epigenesis, Genetic - genetics | Humans | Quality of Life | Male | Prostate-Specific Antigen - metabolism | Disease Progression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Improved Two-Step Click Synthesis of [^sup 18^F]RPS-040: A Prostate Specific Membrane Antigen (PSMA)-Targeted Tracer for Imaging Prostate Cancer (PCa) Using Positron Emission Tomography (PET)
by Wenchao Qu and James Kelly and Alejandro Amor-Coarasa and Nicole waterhouse and Marybeth Dooley and John Babich
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2018, Volume 59, p. 403
Objectives: Recently, a high affinity fluorine-18-labeled Glu-urea-Lys-based inhibitor of PSMA, [18F]RPS-040, was developed in our laboratory as a promising... 
Prostheses | Target recognition | Fluorine | Radioactive tracers | Optimization | Fluoride | Radiochemistry | Tomography | Boiling points | Chemical synthesis | Copper | Distillation | Antigens | Solvents | Medical imaging | Purification | Positron emission | Chemical reactions | Fluorine isotopes | Liquid chromatography | Evaporation | High-performance liquid chromatography | Conversion | Radioactive materials | Urea | Organic chemistry | Impurities | Reaction time | Yield | Prostate cancer | Positron emission tomography | Prostate | Cancer | Phase transfer catalysts
Journal Article
Details down arrow
7. Full Text Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo
by Sun, Yan-Xi and Wang, Jingcheng and Shelburne, Charles E and Lopatin, Dennis E and Chinnaiyan, Arul M and Rubin, Mark A and Pienta, Kenneth J and Taichman, Russell S
Journal of Cellular Biochemistry, ISSN 0730-2312, 06/2003, Volume 89, Issue 3, pp. 462 - 473
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The identification of molecules associated with aggressive... 
Osteoblast | Tumor | Bone | Metastasis | Marrow | Chemokines | GENOMIC ORGANIZATION | CHEMOKINE RECEPTOR CXCR4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | bone | PERIPHERAL-BLOOD | osteoblast | FACTOR-I | chemokines | CELL BIOLOGY | marrow | CELL-DERIVED FACTOR-1 | HEPATOCELLULAR-CARCINOMA | HEMATOPOIETIC PROGENITOR CELLS | MESSENGER-RNA | metastasis | tumor | REDUCED EXPRESSION | Chemokine CXCL12 | Prostatic Neoplasms - metabolism | Coculture Techniques | Humans | RNA, Messenger - genetics | Male | Chemokines, CXC - genetics | DNA Primers | Reverse Transcriptase Polymerase Chain Reaction | Receptors, CXCR4 - metabolism | Culture Media, Conditioned | Base Sequence | Chemokines, CXC - metabolism | Adult | Receptors, CXCR4 - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse
by Hiester, Andreas and Nini, Alessandro and Niegisch, Günter and Arsov, Christian and Hautzel, Hubertus and Antke, Christina and Schimmöller, Lars and Albers, Peter and Rabenalt, Robert
World Journal of Urology, ISSN 0724-4983, 10/2019, Volume 37, Issue 10, pp. 2081 - 2090
To report pre-, postoperative and oncological outcomes in patients treated with spot-specific sLND for patients with exclusive nodal recurrence after PCa... 
Nephrology | Medicine & Public Health | Salvage surgery | Nodal recurrence | Oncology | PET/CT scan | Prostate cancer | Urology | Medical imaging | Computed tomography | Laparoscopy | Patients | Positron emission tomography | Prostate | Morbidity | Lymph nodes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Identification of novel truncated Androgen Receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory Prostate Cancer (PCa) cell line
by Marcias, Gemma and Erdmann, Eva and Lapouge, Gaëlle and Siebert, Christelle and Lémy, Philippe Barthé and Duclos, Brigitte and Bergerat, Jean-Pierre and Raline, Jocelyn Cé and Kurtz, Jean-Emmanuel
Human Mutation, ISSN 1059-7794, 2010, Volume 31, Issue 1, pp. 74 - 80
Advanced prostate cancer (PCa) has emerged as a public health concern due to population aging. Although androgen deprivation has proven efficacy in this... 
Truncated receptor | Aberrant splicing | 22Rv1 | Prostate cancer | Androgen receptor | PCa | prostate cancer | androgen receptor | MUTATION | GROWTH | GENETICS & HEREDITY | aberrant splicing | truncated receptor | Alternative Splicing | Exons | Humans | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Male | RNA Precursors - genetics | Neoplasms, Hormone-Dependent - genetics | Genetic Variation | Prostatic Neoplasms - genetics | Receptors, Androgen - genetics | Cell Line, Tumor | RNA Precursors - metabolism | Mutation | Androgens - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)
by Leapman, Michael S and Westphalen, Antonio C and Ameli, Niloufar and Lawrence, H. Jeffrey and Febbo, Phillip G and Cooperberg, Matthew R and Carroll, Peter R
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0185535
Background We aimed to directly compare results from multi-parametric prostate MRI (mpMRI) and a biopsy-based 17-gene RT-PCR assay providing a Genomic Prostate... 
ACTIVE SURVEILLANCE | MULTIDISCIPLINARY SCIENCES | AGGRESSIVENESS | RADICAL PROSTATECTOMY | RECURRENCE | OUTCOMES | ULTRASOUND-GUIDED BIOPSY | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Gene Expression | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Male | Risk | Neoplasm Proteins - metabolism | Prostate - metabolism | Prostate - pathology | Neoplasm Grading | Prostatic Neoplasms - genetics | Biopsy | Prostate - diagnostic imaging | Prostatic Neoplasms - diagnostic imaging | Aged | Neoplasm Proteins - genetics | Usage | Magnetic resonance imaging | Genetic aspects | Research | Diagnosis | Prostate cancer | Risk factors | Genetic screening | Nuclear magnetic resonance--NMR | Statistical analysis | Categories | Health risks | Malignancy | Gene expression | Patients | Urology | Polymerase chain reaction | Pathology | Mens health | Ultrasonic imaging | Surveillance | Risk assessment | Cell cycle | Men | Diffusion coefficient | Prostate | Cancer | Validation studies | NMR | Nuclear magnetic resonance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
by Gravina, Giovanni Luca and Tortoreto, Monica and Mancini, Andrea and Addis, Alessandro and Di Cesare, Ernesto and Lenzi, Andrea and Landesman, Yosef and McCauley, Dilara and Kauffman, Michael and Shacham, Sharon and Zaffaroni, Nadia and Festuccia, Claudio
Journal of Hematology and Oncology, ISSN 1756-8722, 10/2014, Volume 7, Issue 1, pp. 46 - 46
Background: Exportin 1 (XPO1), also called chromosome region maintenance 1 (CRM1), is the sole exportin mediating transport of many multiple tumor suppressor... 
XPO1 | Selinexor | KPT-330 | CRM1 | Prostate cancer | Bone metastases | Tumor suppressor protein | NUDE-MICE | CELLS IN-VITRO | RECEPTOR | ACUTE MYELOID-LEUKEMIA | ANTICANCER ACTIVITY | PLASMINOGEN-ACTIVATOR | ONCOLOGY | SKELETAL-RELATED EVENTS | SELECTIVE INHIBITORS | BONE METASTASIS | HEMATOLOGY | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Hydrazines - pharmacology | Humans | Osteoblasts - drug effects | Male | Mice, SCID | Blotting, Western | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Animals | Karyopherins - metabolism | Neoplasm Metastasis - pathology | Active Transport, Cell Nucleus - drug effects | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Movement | Receptors, Cytoplasmic and Nuclear - metabolism | Prevention | Metastasis | Patient outcomes | Cancer | Proteins | Studies | Cell growth | Laboratories | Radiation therapy | Cancer therapies | Tumors | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Re: Which Better Predicts Mortality among Older Men, a Prostate Cancer (PCa) Diagnosis or Vulnerability on the Vulnerable Elders Survey (VES-13)? A Retrospective Cohort Study
by Griebling, Tomas L
The Journal of Urology, ISSN 0022-5347, 10/2017, Volume 198, Issue 4, pp. 723 - 724
Prostatic Neoplasms | Humans | Male | Surveys and Questionnaires | Aged | Frail Elderly | Retrospective Studies | Surveys | Prognosis | Diagnosis | Prostate cancer | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text PD43-11 LACK OF SUSTAINABLE RESPONSE TO THE 2012 UNITED STATES PREVENTIVE SERVICES TASK FORCE (USPSTF) RECOMMENDATION AGAINST PROSTATE CANCER (PCA) SCREENING
by Rahbar, Haider and Dalela, Deepansh and Sood, Akshay and Nocera, Luigi and Karabon, Patrick and Rogers, Craig and Peabody, James and Menon, Mani and Trinh, Quoc-Dien and Abdollah, Firas
Journal of Urology, The, ISSN 0022-5347, 2017, Volume 197, Issue 4, pp. e822 - e822
Urology | Task forces | Diagnosis | Prostate cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text The Biological Role and Clinical Significance of Long Noncoding RNA Urothelial Carcinoma Associated 1 (UCA1) in Prostate Cancer (PCa)
by Ghiam, A. Fotouhi and Taeb, S and Huang, X and Jahangiri, S and Ray, J and Hoey, C and Fokas, E and Vesprini, D and Bristow, R.G and Boutros, P.C and Liu, S.K
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 2, pp. S56 - S56
Radiology | Hematology, Oncology and Palliative Medicine | Antisense RNA | Prostate cancer | Radiation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Assessment of Biochemical Outcomes with Increasing Dose Escalation in Localized Prostate Cancer (PCa) Treated with Precision Image Guided Radiation Therapy (IGRT)
by Raziee, H and Murgic, J and Pintilie, M and Chung, P and Menard, C and Bayley, A and Gospodarowicz, M and Warde, P.R and Bristow, R.G and Catton, C.N and Berlin, A
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 2, pp. E228 - E229
Radiology | Hematology, Oncology and Palliative Medicine | Radiotherapy | Prostate cancer | Analysis | Radiation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text MP86-16 A MULTI-CENTER ANALYSIS OF PROSTATE CANCER (PCA) TREATMENT AMONG VETERANS FOLLOWING INTRODUCTION OF THE 17-GENE GENOMIC PROSTATE SCORE (GPS) ASSAY
by Lynch, Julie and Rothney, Megan and Salup, Raoul and Ercole, Cesar and Mathur, Sharad and Duchene, David and Basler, Joseph and Hernandez, Javier and Liss, Michael and Porter, Michael and Wright, Jonathan L and Risk, Michael and Garzotto, Mark and Efimova, Olga and Kemeter, Michael and Denes, Bela and Febbo, Phillip and Dash, Atreya
Journal of Urology, The, ISSN 0022-5347, 2017, Volume 197, Issue 4, pp. e1162 - e1163
Urology | Veterans | Analysis | Genetic research | Genetic aspects | Drug therapy | Prostate cancer | Global Positioning System | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. HOSPITAL BURDEN FOR TREATING PROSTATE CANCER (PCA) WITH BONE METASTASIS (WBM) PATIENTS IN THE BRAZILIAN SUPPLEMENTARY HEALTH SYSTEM: RESULTS FROM A RETROSPECTIVE ANALYSIS OF AN ADMINISTRATIVE DATABASE
by F Tobaruella and SR Rodrigues and S Navarro and C Nakada and EC Paiva and Ed Paloni
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 05/2017, Volume 20, Issue 5, p. A104
OBJECTIVES: Prostate cancer places a high economic burden on healthcare systems globally. International studies demonstrated significant impact to the health... 
Consumption | Hospitalization | Metastasis | Radiation therapy | Burden | Radiotherapy | Patients | Metastases | Averages | Health maintenance organizations | Money | Bone cancer | Cohort analysis | Health care expenditures | Databases | Analytical group psychotherapy | Health care industry | Bones | Prostate cancer | Prostate | Public health | Length of stay | Selection criteria
Journal Article
Details down arrow
18. Full Text The role of individual characteristics in predicting decisional conflict for patients with prostate cancer (PCa): preliminary results
by Bellardita, Lara and Villani, Daniela and Villa, Silvia and Repetto, Claudia and Donegani, Simona and Marchetti, Antonella and Massaro, Davide and Salvioni, Roberto and Magnani, Tiziana and Valdagni, Riccardo
Current Psychology, ISSN 1046-1310, 12/2017, pp. 1 - 10
The principal aim of the study was to investigate the role of individual characteristics in decisional conflict of patients with prostate cancer (PCa) in order... 
Multidisciplinary approach | Anxiety | Decision making | Prostate cancer | Self-efficacy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Lower use of prostate specific antigen testing by cigarette smokers—Another possible explanation for the unfavorable prostate cancer (PCA) specific prognosis in smokers?
by May, Matthias and Maurer, Odilo and Lebentrau, Steffen and Brookman-May, Sabine
Cancer Epidemiology, ISSN 1877-7821, 2016, Volume 46, pp. 34 - 35
  [...]in a present meta-analysis of 51 studies including PCA patients at different tumor stages, Islami et al. revealed that the PCA-specific mortality is... 
Hematology, Oncology and Palliative Medicine | Internal Medicine | MORTALITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SMOKING | HYPERMETHYLATION | ONCOLOGY | Prostate-Specific Antigen | Prostatic Neoplasms | Male | Prognosis | Smokers | Humans | Antigens | Physicians | Mortality | Editing | Cigarettes | Prostate cancer | Manuscripts | Smoking
Journal Article